Sotera Health (NASDAQ:SHC) Issues Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Sotera Health (NASDAQ:SHC) issued its quarterly earnings data on Thursday. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.02), Zacks reports. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. Sotera Health updated its FY 2025 guidance to 0.700-0.760 EPS.

Sotera Health Stock Down 9.3 %

Shares of NASDAQ:SHC traded down $1.27 during midday trading on Thursday, hitting $12.38. 2,007,421 shares of the company’s stock traded hands, compared to its average volume of 923,853. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.08. The company has a market cap of $3.51 billion, a PE ratio of 49.56 and a beta of 1.91. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The firm’s fifty day moving average price is $13.48 and its two-hundred day moving average price is $14.54.

Analysts Set New Price Targets

A number of research firms have recently issued reports on SHC. The Goldman Sachs Group began coverage on Sotera Health in a research report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price target for the company. Citigroup upped their target price on Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $17.00 target price on shares of Sotera Health in a research note on Thursday, November 21st. Finally, Barclays lowered their price target on shares of Sotera Health from $18.00 to $17.00 and set an “overweight” rating on the stock in a research report on Tuesday, February 18th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $16.08.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.